Gabelli lowered shares of Cempra Inc. (NASDAQ:CEMP) from a buy rating to a hold rating in a report issued on Wednesday morning.

A number of other analysts also recently issued reports on CEMP. Jefferies Group cut their price objective on Cempra from $42.00 to $40.00 and set a buy rating for the company in a research report on Tuesday, August 2nd. Robert W. Baird reaffirmed an outperform rating and issued a $33.00 target price on shares of Cempra in a research report on Tuesday, August 2nd. Cowen and Company reaffirmed a buy rating on shares of Cempra in a research report on Tuesday, August 2nd. Needham & Company LLC reaffirmed a buy rating and issued a $48.00 target price on shares of Cempra in a research report on Wednesday, August 3rd. Finally, Zacks Investment Research raised Cempra from a hold rating to a buy rating and set a $25.00 target price for the company in a research report on Thursday, August 4th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Cempra currently has a consensus rating of Hold and an average target price of $19.41.

Shares of Cempra (NASDAQ:CEMP) remained flat at $6.45 during trading on Wednesday. The company’s stock had a trading volume of 1,235,200 shares. The company’s market capitalization is $337.86 million. The firm’s 50-day moving average is $15.30 and its 200 day moving average is $18.83. Cempra has a 52 week low of $5.70 and a 52 week high of $34.24.

Cempra (NASDAQ:CEMP) last issued its quarterly earnings data on Thursday, October 27th. The company reported ($0.62) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.64) by $0.02. The firm earned $4 million during the quarter, compared to the consensus estimate of $3.90 million. Cempra had a negative return on equity of 59.94% and a negative net margin of 678.72%. The company’s quarterly revenue was up 60.0% on a year-over-year basis. During the same period last year, the company earned ($0.63) EPS. Analysts expect that Cempra will post ($2.42) EPS for the current year.

Several hedge funds have recently modified their holdings of CEMP. Palo Alto Investors LLC increased its stake in shares of Cempra by 129.3% in the second quarter. Palo Alto Investors LLC now owns 2,787,542 shares of the company’s stock valued at $45,967,000 after buying an additional 1,571,709 shares in the last quarter. Emerald Acquisition Ltd. bought a new stake in shares of Cempra during the second quarter valued at about $7,850,000. Peregrine Capital Management LLC bought a new stake in shares of Cempra during the third quarter valued at about $9,880,000. BlackRock Fund Advisors increased its stake in shares of Cempra by 14.1% in the third quarter. BlackRock Fund Advisors now owns 1,826,182 shares of the company’s stock valued at $44,194,000 after buying an additional 225,682 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in shares of Cempra by 8.4% in the second quarter. Vanguard Group Inc. now owns 2,830,273 shares of the company’s stock valued at $46,671,000 after buying an additional 220,015 shares in the last quarter. Institutional investors and hedge funds own 77.80% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This report was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another website, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.thecerbatgem.com/2016/11/24/cempra-inc-cemp-downgraded-by-gabelli-to-hold-2.html.

About Cempra

Cempra, Inc is a clinical-stage pharmaceutical company. The Company is focused on developing differentiated antibiotics for the acute care and community settings to meet medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic staphylococcal infections.

5 Day Chart for NASDAQ:CEMP

Receive News & Stock Ratings for Cempra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cempra Inc. and related stocks with our FREE daily email newsletter.